Skip to Main Content Go to Sitemap
SickKids

Chorionic Gonadotropin, Beta - Subunit (Quantitative), serum - Tumour Marker

Alternate test name

Beta-HCG, HCG, HCG Tumour Quant

Lab area
Clinical Biochemistry - General
Method and equipment

Equipment : Roche Cobas Pro e801

Method : The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.

Sandwich principle. Total duration of assay: 18 minutes.
▪ 1st incubation: 6 µL of sample, biotinylated monoclonal hCG‑specific antibodies, and a monoclonal hCG‑specific antibody labeled with a ruthenium complexa) react to form a sandwich complex.
▪ 2nd incubation: After addition of streptavidin-coated microparticles, the complex becomes bound to the solid phase via interaction of biotin and
streptavidin.
▪ The reaction mixture is aspirated into the measuring cell where the microparticles are magnetically captured onto the surface of the electrode. Unbound substances are then removed with ProCell II M. Application of a voltage to the electrode then induces chemiluminescent emission which is measured by a photomultiplier.
▪ Results are determined via a calibration curve which is instrument specific, generated by 2‑point calibration and a master curve provided via the cobas link.

Expected turn-around time
STAT/ Urgent/ Routine: 24 hours
Shipping information
The Hospital for Sick Children
Rapid Response Laboratory
555 University Avenue, Room 3642
Toronto, ON
Canada
M5G 1X8
Phone: 416-813-7200
Toll Free: 1-855-381-3212
Hours: 7 days/week, 24 hours/day
Background and clinical significance

Immunoassay for the in vitro quantitative determination of the sum of human chorionic gonadotrophin (hCG) plus the B-subunit in human serum and plasma.

This assay is intended for use as an aid in:

  • Oncology to serve in the management of patients with trophoblastic disease. This assay is useful in the detection and monitoring of hCG-producing tumor cells of either ovarian, placental or testicular origin.
Back to Top